Woman, 30, Thought Her Heartburn Was Caused by Using Weight-Loss Injections. It Turned Out to Be Aggressive Stomach Cancer
Chloe Stirling recalled how seeking medical help for heartburn led to her being diagnosed with an aggressive form of stomach cancer in a now-viral TikTok video
The NHS nurse, now 30, initially thought the symptom was caused by her diet, but it worsened once she began to use weight-loss injections
"The typical symptoms that you see for stomach cancer, I had none of them,' Stirling said, after revealing she didn't lose weight or have blood in her stoolsA British woman has had her stomach removed after being diagnosed with an aggressive form of cancer at the age of 28.
While updating TikTok followers on her health in a recent video, Chloe Stirling recalled the one symptom that she had before she was diagnosed with signet ring cell adenocarcinoma in March 2024.
The NHS nurse, now 30, said she had been experiencing intermittent heartburn for around a year, which she initially thought was triggered by eating greasy food and drinking alcohol. However, the symptom worsened after she was prescribed weight loss injections in November 2023.
'I didn't have any other symptoms apart from that,' Stirling said of her heartburn, before adding, 'I wasn't losing weight, I wasn't anemic, I didn't have any blood in my stools or anything like that. I wasn't vomiting, and my appetite was brilliant.
'The typical symptoms that you see for stomach cancer, I had none of them,' she said.
Heartburn is a common side effect of using weight loss injections. According to WebMD, 1 in 50 people involved in a Mounjaro clinical trial experienced heartburn, acid reflux, or GERD (Gastroesophageal Reflux Disease).
Stirling said her symptoms largely went away after she stopped taking weight-loss injections, but she still went for an endoscopy in January 2024. A camera was placed down her throat and into her stomach to examine if there was any cause for concern.
Medics told her that she appeared to have an ulcer — an open sore in the stomach — that was almost 'completely healed.' They also said she had Helicobacter pylori (H. pylori), a common bacteria that can cause sores and inflammation in the lining of the stomach or the upper part of the small intestine, according to WebMD. In some cases, the bacteria can also lead to stomach cancer.
'They gave me some treatment and said to come back in six weeks [when they were planning to] check that the ulcer has healed,' Stirling recalled of the medics. 'When I went back in six weeks, that little red mark was still there, so they sent some biopsies off.
'They had not said they were worried about cancer, which they would normally do if they were thinking 'ooh it looks nasty,' ' she continued. 'I was completely blinded when three weeks later I got a phone call to say I have something called signet ring cell adenocarcinoma, which is the most aggressive stomach cancer.'
Stirling was told that the disease was likely caused by the H. pylori that she could have unknowingly had since childhood.
She explained that her diagnosis was followed by a staging laparoscopy — a keyhole operation that involves the use of small cameras to examine inside the abdomen. She then underwent multiple rounds of chemotherapy and had surgery to remove her entire stomach.
Stirling said a CT scan in January 2025 showed that she was 'all clear,' but the surgeons have followed up with her every three months since and she is due to have another CT scan in July.
'Overall, I'm doing really well, getting my strength back,' she said. 'I'm training for a half-marathon in October this year. I'm back in the gym.
'Obviously, I've lost a lot of weight because I don't have a stomach, so my eating is very different now, I have a lot of smaller portions,' she added.
Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
In a follow-up TikTok video, Stirling encouraged viewers to seek medical help if they're regularly experiencing heartburn, although the symptom isn't always an indicator of cancer.
'It's so important to get little things checked out,' she said. 'Even if you just think, 'Oh, I'll just see how it goes.'
'Anything that you just know in your body isn't right, I'd push to go and get it checked,' she added. 'It's what, like 15 minutes out of your day to go to a doctor's appointment that could potentially save your life.'
Read the original article on People
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
25 minutes ago
- New York Post
Man with rare ‘boob' condition is scared to take his top off while dating
A man with 'boobs' due to a rare condition is raising $8,741 (£6.5k) to have them removed – because he is too conscious to take his top off on dates. Thabo Methie, 31, was just 10 years old when he first started noticing he was developing breasts instead of pecks. Sporty Thabo says he was bullied at school, with kids saying they were 'bigger than some of the females.' Thabo stopped participating in sports like swimming at age 11 as he was too self-conscious to take off his top, and he says he became 'sick' of being the brunt of every joke. He went to the doctors and was diagnosed with gynaecomastia – an increase in the amount of breast gland tissue in boys or men. 6 Thabo Methie, 31, was just 10 years old when he first started noticing he was developing breasts instead of pecks. Thabo Methie / SWNS Having lived with the condition for 21 years and worn oversized t-shirts to hide his chest, Thabo has decided that enough is enough. As the surgery is deemed cosmetic, Thabo says it can't be done through the NHS. Instead, he's set up a GoFundMe to raise the $8,741 (£6.5k) required for 'life-changing' private surgery to remove the breast tissue he says has been holding him back for years. Thabo, a healthcare assistant for the NHS blood and transplant service, originally from Marondera, Zimbabwe, but living in Nottingham, Nottinghamshire, said: 'It's not painful, but it has mentally affected me because of how people were to me. 6 Thabo says he was bullied at school, with kids saying they were 'bigger than some of the females.' Thabo Methie / SWNS 'I went for quite a while without dating someone because I didn't want to take my clothes off. 'For such a long time, I would debate getting a knife and cutting it off myself. 'The moment people started making jokes, that really hurt me, and that stuck with me, especially when people pointed them out to me. 'Some girls were laughing about it at school, and the most heartbreaking one was my then-crush telling me that I could breastfeed.' 6 He went to the doctors and was diagnosed with gynaecomastia – an increase in the amount of breast gland tissue in boys or men. Thabo Methie / SWNS When Thabo was 13, he attended boarding school, where his insecurities grew and he became a recluse, trying to avoid any interaction with his peers. He went on to spend the next four years trying to wash when no one would see him, which proved difficult, sharing a communal bathroom with 23 other people. Start your day with all you need to know Morning Report delivers the latest news, videos, photos and more. Thanks for signing up! Enter your email address Please provide a valid email address. By clicking above you agree to the Terms of Use and Privacy Policy. Never miss a story. Check out more newsletters Thabo said: 'My entire life has been about wearing clothes that hide something that makes me deeply embarrassed, and has gotten worse with time. 'Even now, when I want to swim, I worry what people will think of me, and I want my confidence to come back, and I don't want to worry about what other people think of me.' 6 Having lived with the condition for 21 years and worn oversized t-shirts to hide his chest, Thabo has decided that enough is enough. Thabo Methie / SWNS When Thabo was 19, he started to go running to try and prevent his chest from growing any bigger, which actually helped him to an extent. Thabo said, 'This has been ruining my self-esteem, and it's just making me feel depressed most of the time. 'I have added strength training to the running, but these can only do so much, especially as I gain weight. 6 Thabo Methie set up a GoFundMe to raise the $8,741 (£6.5k) required for 'life-changing' private surgery to remove the breast tissue he says has been holding him back for years. Thabo Methie / SWNS 'I started eating healthier with food that has more fibre, and last year I started taking the weight loss injection, but I stopped taking it as it was really expensive.' Thabo's condition is thought to be linked to a hormone imbalance and has significantly impacted his life for over two decades. Though he's maintained an active lifestyle to try and manage it, he has gained 21kg and now weights 19st – and still wears XXXL t-shirts. The breast tissue has grown more with time, affecting his self-esteem and mental health, he said. 6 Methie's condition is thought to be linked to a hormone imbalance and has significantly impacted his life for over two decades. Thabo Methie / SWNS The NHS classifies the surgery as cosmetic and requires long-term UK-based medical records, which Thabo cannot provide due to his recent arrival on a visa since moving to the UK in 2023. Thabo said: 'To have this surgery would mean the world to me. It would be a huge weight off of my shoulders. 'I really hope the surgery can be as soon as possible. When I raise enough money, I will be booking the surgery straight away.'
Newsweek
an hour ago
- Newsweek
Woman Films Morning Gym Walk, Internet Not Prepared for Who's in Window
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. In a viral TikTok video, a woman from New York reveals her favorite thing about her morning gym walks, and internet users can't cope with it. The heartwarming video, shared on Tuesday under the username @erikaedaly, shows a pit bull sleeping on his blanket right by the window, living his best life surrounded by his teddies, and a fairy curtain. "The highlight of my gym walk every morning. Wish I knew his/her name," she writes in the clip. A caption says: "The sparkly curtain and stuffies." If you often find your pup lying on the couch taking a nap, don't worry; that's because dogs sleep much more than we do, and while they might sleep through the night, they still need some daytime naps to recharge their batteries. On average, adult dogs typically need 12 to 14 hours of sleep per day, although this can vary depending on the individual pup. While some pups are naturally more active, and require less sleep, others may enjoy longer naps. A canine's age also plays a role in the amount of sleeping hours they need in a day. For example, puppies, while being incredibly energetic, also need plenty of rest to support their growth. They may sleep as much as 18 to 20 hours a day. Older dogs also need more sleep than their younger counterparts because they need time to rest and recover. Senior pups may sleep for up to 16 hours a day. It is important to provide your senior dog with a comfortable and quiet space to rest, but it is also just as vital to make sure they take regular exercise to help keep them healthy and active. Stock image: A pit bull takes a nap on a cushion. Stock image: A pit bull takes a nap on a cushion. getty images The video quickly went viral on social media and has so far received over 780,000 views and more than 195,000 likes on the platform. One user, Alison Leah, commented: "How do you have enough self control to not go to that window!?" Francesca Zarate posted: "How do you walk by and resist giving her a little kiss on her head." Umi Grace added: "I love how the toys are safely tucked nearby. I wonder how many times her/his human gotta retrieve toys below that window." Newsweek reached out to @erikaedaly for comment. We could not verify the details of the case. Do you have funny and adorable videos or pictures of your pet you want to share? Send them to life@ with some details about your best friend, and they could appear in our Pet of the Week lineup.
Newsweek
2 hours ago
- Newsweek
Weight-Loss Drugs Telehealth Platform Hims & Hers Hit With New Lawsuit
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A stockholder has filed a derivative lawsuit against the board of directors of Hims & Hers, the fast‑growing telehealth platform best known for men's and women's health products—especially its weight‑loss therapies. The suit Jones vs. Dudum names board members and CEO Andrew Dudum in U.S. District Court in San Francisco, arguing that a high-profile partnership gone awry has left the company—and its shareholders—on shaky ground. Newsweek contacted Francis J. Flynn, Jr., Attorney at the Law Office of Francis J. Flynn, Jr. representing Steven Jones in this derivative action on behalf of Hims & Hers Health, Inc., via email on Tuesday for comment. Attorneys for Dudum or the others directors was not listed at time of publication. Dudum, responding to the deal's collapse, last month said Hims & Hers adhered to legal frameworks and accused, accused the drugmaker involved of attempting to steer the company's patients toward its own products. "We refuse to be strong-armed," he said. The other company in the deal Novo Nordisk did not respond to Dudum's remarks, when contacted by Reuters on June 23. Stock image of semaglutide injections. A recent TikTok explained whether you would gain back double the weight after going off weight-loss drugs. Stock image of semaglutide injections. A recent TikTok explained whether you would gain back double the weight after going off weight-loss drugs. Photo by Aplott / Getty Images Why It Matters The dispute raises critical questions for the telehealth industry, including regulatory gray zones such as how far can compounding pharmacies can go under "personalization" rules, especially when dealing in high-demand drugs? And what responsibility do boards have to fully evaluate regulatory risk—even when pursuing innovative deals? What To Know The newly filed lawsuit is not a standard stock drop claim but a derivative suit, meaning it is brought by a shareholder on behalf of the company. A derivative suit places emphasis not just on damages to investors, but on the breach of fiduciary duty owed to the company itself. If the suit is successful, any recovery—whether from settlements or judgments—will go to Hims & Hers, not directly to the suing shareholder. Jones vs. Dudum is the latest of three investor‑initiated lawsuits tied to the collapse of the Wegovy deal. Two earlier securities class action suits were filed last month by investors seeking damages for the sharp drop in share price following the June meltdown. Unlike those class actions—which typically focus on misrepresentation to shareholders—the derivative suit alleges governance failures and corporate mismanagement at the board level. The plaintiff in the new suit alleges that the board and management disseminated misleading statements about the health of a partnership and the legality of its business model, ultimately harming the company's interests. The claim hinges on two major points: first, that the board approved a deal without sufficient due diligence into regulatory exposure; second, that public communications misled investors about the risk of compounding semaglutide and the deal's longevity. Ozempic and rival products like Danish pharmaceutical giant Novo Nordisk's Wegovy have fueled a national obsession with medical weight loss. But pandemic-related demand spikes and supply constraints prompted the FDA to allow compounding pharmacies to produce semaglutide during shortages. While legal, these compounded drugs are not subject to the same regulatory oversight, raising red flags for safety advocates and brand-name drugmakers. Once the shortage was lifted in February 2025, the FDA removed approved semaglutide from its shortage list, signaling that broad compounding should cease. Instead, many including Hims & Hers continued dispensing compounding-based copies under the contested "personalization" rationale—offering customised semaglutide dosages providers argue are tailored to individual patient needs. On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster semaglutide-based weight‑loss injection—to Hims & Hers' digital storefront. The goal was to tap into soaring demand for obesity treatments via a trusted telehealth interface. At the time, Hims & Hers had also been offering compounded semaglutide, a so-called "knock‑off" version of Wegovy, legally produced by compounding pharmacies during the FDA's declared shortage of brand‑name drugs—an arrangement that Novo Nordisk had publicly criticized and challenged as risky and unregulated. In an abrupt June 23 announcement—only two months after the deal was unveiled—Novo Nordisk severed the partnership. The company accused Hims & Hers of "deceptive promotion," arguing that its compounding operations went beyond legal allowances and threatened patient safety. Hims & Hers' stock plummeted. What People Are Saying Him & Hers Founder, Andrew Dudum said in his post on X in June: "In recent weeks, Novo Nordisk's commercial team increasingly pressured us to control clinical standards and steer patients to Wegovy regardless of whether it was clinically best for patients", adding "We refuse to be strong-armed by any pharmaceutical company's anticompetitive demands that infringe on the independent decision making of providers and limit patient choice." Dudum said of the prospect of legal action: "They might take legal action. Others might take legal action. Again, when things are hurting their bottom line in this way, people do all types of things." Dave Moore, executive vice president U.S. operations at Novo Nordisk said in a June 23 release about the deal collapse: "We terminated the deal to protect patients living with obesity", and reaffirmed that only "...authentic, FDA‑approved and regulated Wegovy should be prescribed." He added: "We will work with telehealth companies to provide direct access to Wegovy that share our commitment to patient safety—and when companies engage in illegal sham compounding that jeopardizes the health of Americans, we will continue to take action." And in a Novo corporate statement on July 14, the company said: "Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk." What Happens Next The derivative lawsuit is in its early stage. No hearings or settlement discussions have been reported.
